Synthetic triplex peptide nucleic acid-based inhibitors for cancer therapy
US-2026092085-A1 · Apr 2, 2026 · US
Beth Israel Deaconess Medical Ct Inc holds 594 patents in our database, with recent filings and technology areas summarized below.
| Metric | Value |
|---|---|
| Total patents | 594 |
| Recent patents | 133 |
| First publication | Jul 28, 2016 |
| Latest publication | Apr 2, 2026 |
Year-over-year patent counts for this assignee.
Latest publications where this party is an assignee.
US-2026092085-A1 · Apr 2, 2026 · US
US-2026066119-A1 · Mar 5, 2026 · US
US-12559564-B2 · Feb 24, 2026 · US
US-RE50753-E · Jan 20, 2026 · US
US-2026007699-A1 · Jan 8, 2026 · US
Representative or frequently cited publications from precomputed assignee stats.
US-2026092085-A1 · Apr 2, 2026 · US
US-2026066119-A1 · Mar 5, 2026 · US
US-12559564-B2 · Feb 24, 2026 · US
US-RE50753-E · Jan 20, 2026 · US
US-2026007699-A1 · Jan 8, 2026 · US
Most common classification codes in this portfolio.
| CPC | Patents |
|---|---|
| A61P35/00 | 105 |
| A61K45/06 | 92 |
| A61K2039/505 | 73 |
| A61K39/12 | 67 |
| A61P31/18 | 55 |
Mapped technology topics for this assignee.
| Technology | Patents |
|---|---|
| Human Necessities | 493 |
| Chemistry & Metallurgy | 378 |
| Physics | 191 |
| Cross-Sectional Technologies | 53 |
| Operations & Transport | 20 |
| Mechanical Engineering | 8 |
| Electricity | 2 |
Answers are generated from the same data shown on this page.